“In April, an expert advisory panel for the FDA voted unanimously to recommend Epidiolex’s approval and determined that ‘CBD has a negligible abuse potential.’ The DEA did not immediately respond to Ars’ request for comment. But GW said it expects that the DEA will reschedule CBD within 90 days.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
The Real Story of the Cyprus Debt Crisis
The Wiki Weapon
Europe Sinks ... As Predicted
Government-Approved Workouts? The Fight Against Fitness Licensing.
Fed Chairman Bernanke Admits the Fed Has No Clue
Justin Raimondo: Data-gate Shows We’re On the Cusp
Industrial hemp legalized in California
Florida County Moves To Shut Down Red Light Cameras With Public Vote
Shield Law Defines Journalism So That It Leaves Out Wikileaks & Bloggers
U.S. Secret Service Demands Congress Regulate Cryptocurrencies
CEO of Bigpoint Criticizes Protectionist Posturing from Governments
Farce of Globalism: World Bank Becomes Top Cop?
Estonia opens online applications for world's first e-residency program
Gun Control Laws Increasingly Irrelevant as 3D Printed Rifle Receiver Fires Hundreds of Rounds
CIA’s big data mission: ‘Collect everything and hang onto it forever’